Table 1.
The correlation between clinicopathological parameters and LNCEIF3J-AS1 expression in human esophageal cancer.
| Clinical features | Total (N = 182) | LNCEIF3J-AS1 | p-value | |
|---|---|---|---|---|
| Low (N = 91) | High (N = 91) | |||
| Age (years) | 0.105 | |||
| < 60 | 54 (29.7%) | 22 (12.1%) | 32 (17.6%) | |
| ≥ 60 | 128 (70.3%) | 69 (37.9%) | 59 (32.4%) | |
| Gender | 0.765 | |||
| Male | 102 (56%) | 52 (28.6%) | 50 (27.5%) | |
| Female | 80 (44%) | 39 (21.4%) | 41 (22.5%) | |
| Differentiation grade | 0.432 | |||
| Well | 61 (33.5%) | 28 (15.4%) | 33 (18.1%) | |
| Moderate + poor | 121 (66.5%) | 63 (34.6%) | 58 (31.9%) | |
| TNM stage | 0.014 | |||
| I + II | 114 (62.6%) | 65 (35.7%) | 49 (26.9%) | |
| III | 68 (37.4%) | 26 (14.3%) | 42 (23.1%) | |
| Depth of invasion | 0.001 | |||
| T1 + T2 | 85 (46.7%) | 54 (29.7%) | 31 (17%) | |
| T3 + T4 | 97 (53.3%) | 37 (20.3%) | 60 (33%) | |
| Lymph node metastasis | < 0.001 | |||
| No | 120 (65.9%) | 79 (43.4%) | 41 (22.5%) | |
| Yes | 62 (34.1%) | 12 (6.6%) | 50 (27.5%) | |
Pearson chi-square test was used for comparison between subgroups.
Bold values indicate p-value < 0.05.